Lindsey Trickett
Investor Relations Contact bei F-STAR THERAPEUTICS, INC.
Profil
Lindsey Trickett is currently the Vice President of Investor Relations at Prelude Therapeutics, Inc. and the VP of Investor Relations & Communications at F-star Therapeutics, Inc. She previously worked as the Vice President of Investor Relations at Intellia Therapeutics, Inc. Ms. Trickett received an undergraduate degree from the University of Kentucky and an MBA from Georgetown University.
Aktive Positionen von Lindsey Trickett
| Unternehmen | Position | Beginn |
|---|---|---|
| F-STAR THERAPEUTICS, INC. | Investor Relations Contact | - |
| PRELUDE THERAPEUTICS INCORPORATED | Investor Relations Contact | - |
Ehemalige bekannte Positionen von Lindsey Trickett
| Unternehmen | Position | Ende |
|---|---|---|
| INTELLIA THERAPEUTICS, INC. | Investor Relations Contact | - |
Ausbildung von Lindsey Trickett
| University of Kentucky | Undergraduate Degree |
| Georgetown University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| INTELLIA THERAPEUTICS, INC. | Health Technology |
| PRELUDE THERAPEUTICS INCORPORATED | Health Technology |
| Private Unternehmen | 1 |
|---|---|
F-star Therapeutics, Inc.
 F-star Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology F-star Therapeutics, Inc. is a clinical-stage immuno-oncology company. It focuses on transforming the lives of patients with cancer through the development of tetravalent mAb2 bispecific antibodies. The firm's product candidate, FS118, simultaneously targets two immune checkpoint receptors, LAG-3 and PD-L1, to directly address known tumor evasion pathways. The company was founded on October 7, 2002 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
